Epigenetic Signatures in Arterial Hypertension: Focus on the Microvasculature

Alessandro Mengozzi1,2,3, Sarah Costantino1,4, Alessia Mongelli1

  • 1Center for Translational and Experimental Cardiology (CTEC), Zurich University Hospital, University of Zurich, 8952 Schlieren, Switzerland.

Insights

Epigenetic changes contribute to arterial hypertension (AH) by altering gene expression in blood vessels, leading to long-lasting effects. These epigenetic factors are key in microvascular dysfunction associated with AH.

Area of Science:

  • Cardiovascular Science
  • Epigenetics
  • Vascular Biology

Background:

  • Systemic arterial hypertension (AH) is linked to vascular aging and significant cardiometabolic risks.
  • The precise pathogenesis of AH is not fully understood, and effective treatments are limited.
  • Epigenetic signals are increasingly recognized for their role in regulating genes involved in vascular remodeling and sympathetic activation in AH.

Purpose of the Study:

  • To review the emerging role of epigenetic modifications in hypertensive-related microvascular disease.
  • To explore the cellular and tissue-specific epigenetic changes in endothelial cells, vascular smooth muscle cells, and perivascular adipose tissue.
  • To examine the influence of mechanical and hemodynamic factors, such as shear stress, on these epigenetic alterations.

Main Methods:

  • Literature review focusing on epigenetic mechanisms in arterial hypertension.
  • Analysis of studies investigating cellular and molecular changes in microvasculature.
  • Inclusion of research on the impact of hemodynamic forces on epigenetic regulation.

Main Results:

  • Epigenetic changes play a significant role in maladaptive vascular remodeling and cardiometabolic alterations predisposing to AH.
  • These epigenetic alterations can have persistent effects on gene dysregulation, often resisting reversal.
  • Microvascular dysfunction is a central component of AH, influenced by epigenetic factors across various cell types.

Conclusions:

  • Epigenetic modifications are crucial in the development and persistence of hypertensive microvascular disease.
  • Understanding these epigenetic mechanisms offers potential new therapeutic targets for managing AH.
  • The interplay between cellular epigenetic changes and hemodynamic forces is vital in AH pathogenesis.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
27
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.2K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
36
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
35
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
40
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
3.0K